For example, the PI3K/Akt oncogenic pathway is activated in variety of malignant tumors induced by PIP3, and inhibition of the PI3K/Akt pathway is a highly specific molecular target for the development of molecular therapeutics with aberrant PI3K expression.119, 263. Here, AKT1 is linked to cancer.